Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins MWG Operon and Genomatix Partner to Provide Next-Gen Sequencing Services


This story was originally published July 8.

DNA service provider Eurofins MWG Operon and German bioinformatics firm Genomatix Software have teamed up to provide genome analysis and resequencing project services, the companies said last week.

Under the exclusive partnership, which builds on previous collaborations on several projects, the firms will offer next-gen sequencing as well as read mapping, analysis of ChIP-seq and digital gene expression data, and annotation services, according to the Eurofins website.

Eurofins MWG Operon, which resulted from the merger of MWG Biotech, Operon Biotechnologies, and Medigenomix, provides DNA sequencing and oligonucleotide synthesis services. The company, which has headquarters in Ebersberg, Germany, and Huntsville, Ala., provides next-generation sequencing services on the 454 GS FLX and Illumina GA platforms, according to its website.

Genomatix Software, headquartered in Munich, offers data analysis solutions for next-generation sequencing called Genomatix Genome Analyzer and Genomatix Mining Station.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.